A Phase II Prospective Trial of Prophylactic Donor Lymphocyte Infusions for the Prevention of Relapse post HSCT in patients with High Risk Myeloid Malignancy

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201531/05/2019

Collaborative partners

Funding

  • Blood Cancer UK: £43,226.00